General Information of the Compound
Compound ID
CP0361103
Compound Name
5-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]-1H-thieno[3,2-c]pyrazole
    Show/Hide
Structure
Formula
C14H11N9S
Molecular Weight
337.372
Canonical SMILES
Cn1cc(cn1)-c1cnc2nnn(Cc3cc4[nH]ncc4s3)c2n1
    Show/Hide
InChI
InChI=1S/C14H11N9S/c1-22-6-8(3-17-22)11-4-15-13-14(18-11)23(21-20-13)7-9-2-10-12(24-9)5-16-19-10/h2-6H,7H2,1H3,(H,16,19)
    Show/Hide
InChIKey
LHOBRKZKLMMCMG-UHFFFAOYSA-N
Physicochemical Property
logP
1.6079
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
102.99
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
9
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 68355550
ChEMBL ID
CHEMBL3334541
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01201, Hepatocyte growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000450 NCI-H441 Homo sapiens (Human)  1
1
IC50 = 19 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 6 nM